BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10952773)

  • 21. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
    Gibson MK; Holcroft CA; Kvols LK; Haller D
    Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal medullary carcinoma: case report and review of the literature.
    Noguera-Irizarry WG; Hibshoosh H; Papadopoulos KP
    Am J Clin Oncol; 2003 Oct; 26(5):489-92. PubMed ID: 14528077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapy.
    Stathopoulos GP; Rigatos SK; Malamos NA; Stathopoulos JG; Thallasinou P; Papazachariou E; Antoniou F; Kondopodis E; Xynotroulas J
    Oncol Rep; 2004 Dec; 12(6):1295-300. PubMed ID: 15547753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
    Kudriavtsev DV; Kudriavtseva GT; Mardynskiĭ IuS
    Vopr Onkol; 2008; 54(2):170-7. PubMed ID: 18522165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial serum calcitonin concentrations to evaluate response to therapy of patients with medullary thyroid carcinoma.
    Athanassiades P; Piperingos G; Pandos P; Koutras D; Moulopoulos S
    Chemioterapia; 1988 Jun; 7(3):195-7. PubMed ID: 3168076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Feugier P; Van Hoof A; Sebban C; Solal-Celigny P; Bouabdallah R; Fermé C; Christian B; Lepage E; Tilly H; Morschhauser F; Gaulard P; Salles G; Bosly A; Gisselbrecht C; Reyes F; Coiffier B
    J Clin Oncol; 2005 Jun; 23(18):4117-26. PubMed ID: 15867204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phase I study of the combination of nedaplatin (NED), adriamycin (ADM), and 5-fluorouracil (5-FU) (NAF) for treatment of unresectable advanced esophageal cancer].
    Hirao M; Fujitani K; Tsujinaka T
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):53-6. PubMed ID: 15675582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.
    Sørbye H; Glimelius B; Berglund A; Fokstuen T; Tveit KM; Braendengen M; Øgreid D; Dahl O
    J Clin Oncol; 2004 Jan; 22(1):31-8. PubMed ID: 14701765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin.
    Gonzalez MA; Biswas S; Clifton L; Corrie PG
    Br J Cancer; 2003 Aug; 89(3):455-6. PubMed ID: 12888810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
    Ardavanis A; Mavroudis D; Kalbakis K; Malamos N; Syrigos K; Vamvakas L; Kotsakis A; Kentepozidis N; Kouroussis C; Agelaki S; Georgoulias V;
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):742-8. PubMed ID: 16718470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
    Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
    Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide.
    Lupoli G; Cascone E; Arlotta F; Vitale G; Celentano L; Salvatore M; Lombardi G
    Cancer; 1996 Sep; 78(5):1114-8. PubMed ID: 8780551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combretastatin A-4 and doxorubicin combination treatment is effective in a preclinical model of human medullary thyroid carcinoma.
    Nelkin BD; Ball DW
    Oncol Rep; 2001; 8(1):157-60. PubMed ID: 11115589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
    Engstrom PF; Lavin PT; Moertel CG; Folsch E; Douglass HO
    J Clin Oncol; 1984 Nov; 2(11):1255-9. PubMed ID: 6238136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
    Stein R; Chen S; Reed L; Richel H; Goldenberg DM
    Cancer; 2002 Jan; 94(1):51-61. PubMed ID: 11815960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
    de Vries H; Mulder NH; de Vries EG
    Cancer; 2000 May; 88(9):2194-5. PubMed ID: 10813734
    [No Abstract]   [Full Text] [Related]  

  • 37. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.
    Stein R; Goldenberg DM
    Mol Cancer Ther; 2004 Dec; 3(12):1559-64. PubMed ID: 15634649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium.
    Matuszczyk A; Petersenn S; Bockisch A; Gorges R; Sheu SY; Veit P; Mann K
    Horm Metab Res; 2008 Mar; 40(3):210-3. PubMed ID: 18348081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis).
    Franc B; Rosenberg-Bourgin M; Caillou B; Dutrieux-Berger N; Floquet J; Houcke-Lecomte M; Justrabo E; Lange F; Labat-Moleur F; Le Bodic MF; Patey M; Beauchet A; Saint-André JP; Hejblum G; Viennet G
    Hum Pathol; 1998 Oct; 29(10):1078-84. PubMed ID: 9781645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
    Rivera E; Ajani JA
    Am J Clin Oncol; 1998 Feb; 21(1):36-8. PubMed ID: 9499254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.